Prescription Opioids Hydrocodone, Oxycodone, Oxymorphone, Morphine, Codeine, Fentanyl
Total Page:16
File Type:pdf, Size:1020Kb
Recognizing Symptoms of Drugs of Abuse Maricel Dela Cruz DO, MPH, FAWM It is the policy of the Intensive Osteopathic Update (IOU) organizers that all individuals in a position to control content disclose any relationships with commercial interests upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflict of interest (COI), and if identified, conflicts are resolved prior to confirmation of participation. Only those participants who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this CME activity. All faculty in a position to control content for this session have indicated they have no relevant financial relationships to disclose. The content of this material/presentation in this CME activity will not include discussion of unapproved or investigational uses of products or devices. Faculty Disclosure I have no relevant financial relationships to disclose. The content of this material/presentation in this CME activity will not include discussion of unapproved or investigational uses of products or devices. Learning Objectives • Define illicit and illegal drug abuse • List common drugs of abuse as identified by the National Institute on Drug Abuse • Describe evidence-based screening tools to recognize a history of drug abuse in the outpatient setting • Describe signs and symptoms of drug abuse associated with common drugs of abuse • Demonstrate the current recommendations regarding drug abuse screening as per the United States Preventive Services Task Force Definition The use of illegal drugs or the use of prescription or over-the-counter drugs for purposes other than those for which they are meant to be used, or in large amounts. Drug abuse may lead to social, physical, emotional, and job-related problems. Background 2018 National Survey on Drug Use and Health More than 19% of all people ages 12 and older in the United States used an illicit drug in the past year More than 53 million Americans Illicit drug use is the most common cause of preventable morbidity and death in the United States Drug Use Screening in Adults American Academy of Family Physicians. Screen Adults for Unhealthy Drug Use, Says Task Force. https://www.aafp.org/news/health-of-the-public/20200616uspstf-illicitdrugscreen.html. United States Preventive Services Task Force June 9, 2020 United States Preventive Services Task Force. Unhealthy Drug Use: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening. Recommendations USPSTF recommends that clinicians screen patients 18 and older by asking about unhealth drug use Screening should occur when accurate diagnosis, effective treatment and appropriate care can be offered or referred Insufficient evidence to assess the balance of benefits and harms of screening for unhealthy drug use in adolescents ages 12-17 Evidence USPSTF performed a systematic review that included 99 studies 28 studies focused on the accuracy of drug screening instruments 71 studies addressed specific therapies, such as psychosocial interventions, opioid agonist therapy and naltrexone, to reduce drug use Screening Tools (Examples) Substance Use Brief Screen (SUBS) Tobacco, Alcohol, Prescription Medication and Other Substance Use Tool (TAPS) Drug Abuse Screening Test (DAST) Single-Item Drug Frequency Questions (AUDIT-C, etc.) Substance Use Brief Screen (SUBS) Han BH, Sherman SE, Link AR, Wang B, McNeely. Comparison of the Substance Use Brief Screen (SUBS) to the AUDIT-C and ASSIST for detecting unhealthy alcohol and drug use in a population of hospitalized smokers. Journal of Substance Abuse Treatment. 2017. DOI: 10.1016/j.jsat.2017.05.014. Tobacco, Alcohol, Prescription Medication and Other Substance Use Tool (TAPS) https://cde.drugabuse.gov/sites/nida_cde /files/TAPS%20Tool%20Parts%20I%20and %20II%20V2.pdf Drug Abuse Screening Test (DAST) The Drug Abuse Screening Test (DAST) - United States ...www.uspreventiveservicestaskforce.org Drugs of Abuse List Ethanol MDMA Club Drugs Methamphetamines Cocaine Opioids Fentanyl Over-the-Counter Medicines Hallucinogens Prescription Medications Heroin Steroids (Anabolic) Inhalants Synthetic Cannabinoids Kratom Synthetic Cathinones Marijuana Tobacco/Nicotine and Vaping https://www.drugabuse.gov/drug-topics/commonly-used-drugs-charts Ethanol Increase in neurotransmitter gamma- aminobutyric acid (GABA), an inhibitory neurotransmitter. Suppresses the central nervous system. Decrease in anxiety, poor fine motor skills, euphoria, stupor. https://openphoto.net/gallery/name/illustration/1505 Addiction, long term liver disease, cardiovascular disease and cancer. Club Drugs GHB – CNS depressant, binds to the receptors of the inhibitory neurotransmitter GABA, particularly GABA-B. Rohypnol (flunitrazepam) – CNS depressant, leads to anterograde amnesia, CNS depressant, binds to receptors of GABA, particularly GABA-A. Ketamine – NMDA (N-methyl-D-aspartate) receptor antagonists, leads to anesthetic, analgesic and dissociative effects. Can lead to leukocytosis, low glucose and rhabdomyolysis. https://commons.wikimedia.o rg/wiki/File:AbuGnost_anaboli c_steroids_GHB_poppers_080 LSD – activates serotonin receptors (5HT2A receptors), 810_48.jpg modulates others (5HT2C and 5HT1A), leading to impaired cognition and induction of hallucinations. GABA-A versus GABA-B receptors GABA-A receptors are GABA-B receptors are G- ligand-gated ion channels protein-coupled receptors (inotropic receptors), (metabotropic receptors), produce sedative and produce sedative effects. hypnotic effects with anti- Can lead to changes in convulsion properties. gene transcription. https://www.researchgate.net/figure/Fig-3-Schematic- https://alchetron.com/GABA-receptor representation-of-the-GABA-B-receptor_fig2_286488910 Cocaine Base – crack, free base, rock crystals that vaporize when heated to smoke making a “crackling noise”; Salt – blow, coke, snow. Stimulant, from leaves of coca plant, native to South America. Leads to central and peripheral nervous system effects, blocking the reuptake of monoamine transporters (Dopamine, Norepinephrine and Serotonin). Tremor, alertness, hypertension, euphoria. Acute MI, aortic dissection, CVA, seizures. Hallucinations, hyperthermia, paranoia. Crack lung (diffuse alveolar damage. https://www.pexels.com/photo/black-black-and-white-business-cocaine-322251/ https://commons.wikimedia.org/wiki/File:Kokain_-_Cocaine.svg Hallucinogens Alter perception (awareness of surrounding objects and conditions), thoughts, and feelings. Lead to hallucinations, or sensations and images that seem real though they are not. Primarily affect 5HT2A receptors (serotonin). Can be found in plants and mushrooms or are human-made. Ayahuasca, LSD, peyote (mescaline), 4-phosphoryloxy-N, N- dimethyltryptamine (psilocybin). https://commons.wikimedia.org/wiki/File:Peyote_Cactus.jpg https://en.wikipedia.org/wiki/File:Psilocybe_semilanceata_6514.jpg Inhalants Chemical vapors or gases that produce a “high” when inhaled. Solvents – benzene, toluene, xylene, acetone, naptha, hexane Aerosol Sprays – hair spray, spray paint, cooking spray, pressurized liquids or gases (fluorocarbon, butane) Gases – nitrous oxide (“laughing gas”), chloroform, halothane, https://www.lejeune.marines.mil/Ne ws/Article/511694/a-cheap-way-to- ether, butane lighters, propane tanks get-high-a-quick-way-to-die/ Nitrites – amyl nitrite, butyl nitrite, cyclohexyl nitrite (poppers) Can cause cardiac sensitization (dysrhythmias), methemoglobinemia. Kratom Southeast Asian tropical tree with weak opioid effects. Used as a supplement to treat chronic pain and opioid withdrawal. Smoked or brewed in tea; can also chew on leaves. Stimulant-like effects at lower doses, opioid at higher. Withdrawal can occur when stopped. Addiction potential. https://commons.wikimedia.org/wiki/File:Kratom_leaves.jpg Marijuana Dried leaves, flowers, stems, and seeds from the hemp plant, Cannabis sativa. Plant contains the chemical delta-9-tetrahydrocannabinol (THC) and other related compounds. Partial agonist of CB1 and CB2 cannabinoid receptors. Extracts can also be made from the cannabis plant. Giddiness, feeling of well being, euphoria, relaxation, altered perception of time, drowsiness, diminished coordination, increased appetite, increased risk of psychosis, diminished cognitive function, withdrawal. https://pixabay.com/photos/marijuana-leaves-cannabis-green-3678222/ MDMA (3,4-methylenedioxymethamphetamine) Ecstasy, Lover’s Speed, Molly, X. Sympathomimetic, Hallucinogenic and Psychedelic Effects. Increased energy and pleasure, enhanced tactile stimulation. Indirect effect on the serotonin receptor (5HT2A). Stimulates release of dopamine, serotonin and norepinephrine, as well as cortisol, oxytocin and ADH. Can last up to 3-6 hours, repeated doses to maintain high. 10x greater serotonin release than methamphetamine, causing intense mood effects. https://commons.wikimedia.org/wiki/File:MDMA2.jpg Methamphetamine Chalk, crank, crystal, glass, ice, meth. Oral, smoke, snort, inject. Blocks reuptake of monoamines (dopamine, norepinephrine, serotonin). Stimulates dopamine release causing a longer duration of action. Sympathomimetic, dysrhythmias, hypertension, hyperthermia, acute MI, insomnia, seizures, stroke, rhabdomyolysis. Weight loss, impaired verbal and learning. Cardiomyopathy, psychiatric disorders. https://commons.wikimedia.org/wiki/File:Suspectedmethmouth09-19-05closeup.jpg https://commons.wikimedia.org/wiki/File:Crystal_Meth.jpg Over